Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers’s Drug Combination Boosts Lung Cancer Benefit
Bloomberg
Sat, 06/4/16 - 06:23 pm
Bristol-Myers Squibb
Yervoy
Opdivo
metastatic non-small cell lung cancer
Will Bristol-Myers Squibb Checkmate Colorectal Cancer Now?
Seeking Alpha
Fri, 06/3/16 - 09:50 pm
Bristol-Myers Squibb
colorectal cancer
Opdivo
3 Stories To Watch At The Year’s Biggest Cancer Conference
Investors.com
Mon, 05/30/16 - 06:34 pm
ASCO 2016
Pfizer
Eli Lilly
breast cancer
Ibrance
abemaciclib
AbbVie
non-small cell lung cancer
Rova-T
Keytruda
Bristol-Myers Squibb
Merck
Opdivo
Why Eliquis Matters to Bristol-Myers Squibb’s Cardiovascular Business
Yahoo/Market Realist
Mon, 05/30/16 - 06:20 pm
Bristol-Myers Squibb
Eliquis
Bet You Can't Guess Which of These 10 Big Pharma Names Has the Largest Late-Stage Pipeline
Motley Fool
Mon, 05/30/16 - 10:13 am
JNJ
Pfizer
Novartis
Merck
Bristol-Myers Squibb
GSK
Sanofi
AbbVie
Eli Lilly
AstraZeneca
Merck, Bristol drugs show longer survival for deadly cancers
Yahoo/Reuters
Thu, 05/19/16 - 09:59 am
Merck
Bristol-Myers Squibb
cancer immunotherapy
lung cancer
melanoma
Opdivo
Keytruda
ASCO 2016
Bristol-Myers, AbbVie open two new facilities this week that will employ 250
Bizjournals.com
Tue, 05/17/16 - 05:49 pm
Bristol-Myers Squibb
AbbVie
drug manufacturing
Bristol-Myers extends lead with new Opdivo indication
BioPharma Dive
Tue, 05/17/16 - 05:20 pm
Bristol-Myers Squibb
Opdivo
Hodgkin's lymphoma
FDA
Merck May Need More Than Just Bolt-On Acquisitions
Seeking Alpha
Thu, 05/12/16 - 09:45 am
Merck
AbbVie
Bristol-Myers Squibb
Pfizer
Gilead Sciences
M&A
Amgen's Kyprolis stands its ground against new J&J, BMS rivals
Fierce Pharma
Wed, 05/4/16 - 09:48 am
Amgen
Kyprolis
JNJ
Bristol-Myers Squibb
Multiple Myeloma
Darzalex
Empliciti
AbbVie
Takeda
Ninlaro
Commonly used drug can cause uncontrollable urge to gamble and have sex, FDA says
Stat
Tue, 05/3/16 - 09:53 pm
Abilify
antipsychotic
FDA
Otsuka
Bristol-Myers Squibb
Bristol raises 2016 forecast after earnings beat
Yahoo/Reuters
Thu, 04/28/16 - 09:45 am
Bristol-Myers Squibb
earnings
How Will Bristol-Myers (BMY) Stock React to Thursday's Q1 Earnings?
TheStreet.com
Wed, 04/27/16 - 10:02 pm
Bristol-Myers Squibb
earnings
Bristol-Myers Squibb Co Q1 Earnings: Here’s What to Expect
Bidness, ETC
Wed, 04/27/16 - 02:12 pm
Bristol-Myers Squibb
earnings
Roche Still Waiting For The Big Push
Seeking Alpha
Tue, 04/26/16 - 09:55 am
Roche
ASCO
immuno-oncology
Amgen
Merck
Bristol-Myers Squibb
Goldman Sach's 5 Large-Cap Pharma Stock Favorites Ahead of Earnings
TheStreet.com
Mon, 04/25/16 - 08:06 am
earnings
Bristol-Myers Squibb
AbbVie
Allergan
Teva Pharmaceutical
Mylan
Bristol-Myers Squibb’s Opdivo® (nivolumab) Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Yahoo
Mon, 04/25/16 - 08:02 am
Bristol-Myers Squibb
Opdivo
metastatic head and neck squamous cell carcinoma
Can Humira Still Dominate In 2022?
Seeking Alpha
Thu, 04/21/16 - 03:28 pm
Humira
Amgen
Bristol-Myers Squibb
Coherus Biosciences
Gilead Sciences
Intercept Pharma
JNJ
Novartis
Pfizer
Bristol-Myers's Opdivo Extends Survival in Head, Neck Cancer
Bloomberg
Tue, 04/19/16 - 06:14 pm
Bristol-Myers Squibb
Opdivo
head and neck cancer
Bristol Myers Set to Enhance Dominance in Immunotherapies Market
Bidness, ETC
Sat, 04/16/16 - 04:10 pm
Bristol-Myers Squibb
Opdivo
cancer immunotherapy
Hodgkin's lymphoma
Pages
« first
‹ previous
…
30
31
32
33
34
35
36
37
38
…
next ›
last »